These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 14514686)
1. Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor beta1-induced apoptosis of rat hepatocytes. Sola S; Ma X; Castro RE; Kren BT; Steer CJ; Rodrigues CM J Biol Chem; 2003 Dec; 278(49):48831-8. PubMed ID: 14514686 [TBL] [Abstract][Full Text] [Related]
2. Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes. Solá S; Castro RE; Kren BT; Steer CJ; Rodrigues CM Biochemistry; 2004 Jul; 43(26):8429-38. PubMed ID: 15222754 [TBL] [Abstract][Full Text] [Related]
3. p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis. Amaral JD; Castro RE; Solá S; Steer CJ; Rodrigues CM J Biol Chem; 2007 Nov; 282(47):34250-9. PubMed ID: 17881359 [TBL] [Abstract][Full Text] [Related]
4. Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF-beta1-induced apoptosis in rat hepatocytes. Solá S; Amaral JD; Castro RE; Ramalho RM; Borralho PM; Kren BT; Tanaka H; Steer CJ; Rodrigues CM Hepatology; 2005 Oct; 42(4):925-34. PubMed ID: 16175607 [TBL] [Abstract][Full Text] [Related]
5. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells. Fan G; Ma X; Kren BT; Steer CJ Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of the E2F-1/p53/Bax pathway by tauroursodeoxycholic acid in amyloid beta-peptide-induced apoptosis of PC12 cells. Ramalho RM; Ribeiro PS; Solá S; Castro RE; Steer CJ; Rodrigues CM J Neurochem; 2004 Aug; 90(3):567-75. PubMed ID: 15255934 [TBL] [Abstract][Full Text] [Related]
7. p53 dephosphorylation and p21(Cip1/Waf1) translocation correlate with caspase-3 activation in TGF-beta1-induced apoptosis of HuH-7 cells. Fan G; Ma X; Wong PY; Rodrigues CM; Steer CJ Apoptosis; 2004 Mar; 9(2):211-21. PubMed ID: 15004518 [TBL] [Abstract][Full Text] [Related]
8. [Ursodeoxycholic acid inhibits hepatocyte-like cell apoptosis by down-regulating the expressions of Bax and Caspase-3]. Ji WJ; Qu Q; Jin Y; Zhao L; He XD Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2997-3001. PubMed ID: 20137712 [TBL] [Abstract][Full Text] [Related]
9. Unbound E2F modulates TGF-beta1-induced apoptosis in HuH-7 cells. Fan G; Ma X; Kren BT; Steer CJ J Cell Sci; 2002 Aug; 115(Pt 15):3181-91. PubMed ID: 12118073 [TBL] [Abstract][Full Text] [Related]
11. Modulation of hepatocyte apoptosis: cross-talk between bile acids and nuclear steroid receptors. Solá S; Amaral JD; Aranha MM; Steer CJ; Rodrigues CM Curr Med Chem; 2006; 13(25):3039-51. PubMed ID: 17073645 [TBL] [Abstract][Full Text] [Related]
12. X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-beta1) through ubiquitin-mediated proteosomal degradation of the TGF-beta1-activated kinase 1 (TAK1). Kaur S; Wang F; Venkatraman M; Arsura M J Biol Chem; 2005 Nov; 280(46):38599-608. PubMed ID: 16157589 [TBL] [Abstract][Full Text] [Related]
13. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease. Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550 [TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid modulates the ubiquitin-proteasome degradation pathway of p53. Amaral JD; Castro RE; Solá S; Steer CJ; Rodrigues CM Biochem Biophys Res Commun; 2010 Oct; 400(4):649-54. PubMed ID: 20807506 [TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Rodrigues CM; Ma X; Linehan-Stieers C; Fan G; Kren BT; Steer CJ Cell Death Differ; 1999 Sep; 6(9):842-54. PubMed ID: 10510466 [TBL] [Abstract][Full Text] [Related]
16. The transcription factor E2F-1 modulates TGF-beta1 RNA expression in glial cells. Thatikunta P; Raj GV; Kundu M; Khalili K; Amini S Oncogene; 1997 Jun; 14(24):2959-69. PubMed ID: 9205103 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of hepatitis C virus core protein expression in immortalized human hepatocytes induces cytochrome c-independent increase in Apaf-1 and caspase-9 activation for cell death. Meyer K; Basu A; Saito K; Ray RB; Ray R Virology; 2005 Jun; 336(2):198-207. PubMed ID: 15892961 [TBL] [Abstract][Full Text] [Related]
18. Apoptosis and modulation of cell cycle control by synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid in human prostate cancer cells. Choi YH; Im EO; Suh H; Jin Y; Yoo YH; Kim ND Cancer Lett; 2003 Sep; 199(2):157-67. PubMed ID: 12969788 [TBL] [Abstract][Full Text] [Related]
19. Attenuating effects of heat shock against TGF-beta1-induced apoptosis in cultured rat hepatocytes. Díez-Fernández C; Andrés D; Cascales M Free Radic Biol Med; 2002 Sep; 33(6):835-46. PubMed ID: 12208371 [TBL] [Abstract][Full Text] [Related]
20. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. Rodrigues CM; Fan G; Ma X; Kren BT; Steer CJ J Clin Invest; 1998 Jun; 101(12):2790-9. PubMed ID: 9637713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]